HIGH-RISK CUTANEOUS SQUAMOUS CELL CARCINOMA. A PRACTICAL GUIDE FOR PATIENT MANAGEMENT

HIGH-RISK CUTANEOUS SQUAMOUS CELL CARCINOMA. A PRACTICAL GUIDE FOR PATIENT MANAGEMENT

Editorial:
SPRINGER
Año de edición:
Materia
Dermatología
ISBN:
978-3-662-47080-0
Páginas:
255
N. de edición:
1
Idioma:
Inglés
Ilustraciones:
35
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

135,19 €

Despues:

128,43 €

1. Epidemiology and Outcomes of Cutaneous Squamous Cell Carcinoma
2. Tumor Staging Systems and Prognostic Stratification
3. Genomics of SCC: Tumor Formation, Progression, and Future Therapeutic Implications for High-Risk Cutaneous Squamous Cell Carcinoma
4. Molecular and Cellular Interplay in SCC Including Immunomodulation and Clinical Implications
5. Management of Patients with Multiple SCCs/Field Cancerization
6. Management of High-Risk Primary Tumors Including Nodal Staging
7. Management of Local Recurrence and In-Transit Metastasis
8. Management of Nodal Metastases
9. Management of Widely Metastatic and Unresectable Cutaneous Squamous Cell Carcinoma
10. Immune Dysfunction and Immunosuppression: Impacts on SCC Incidence, Prognosis, and Management

This book is a cutting-edge resource that provides clinicians with the up-to-date practical knowledge required in order to manage SCC patients optimally. It summarizes newly available information relating to the definition of high-risk SCC, its pathophysiologic underpinnings, and its management. New prognostic information and staging systems are summarized that enable high-risk tumors to be defined more precisely than ever before. Many helpful tips are provided on the practical management of challenging cases, including multiple tumors/field cancerization, high-risk tumors, nodal metastases, and unresectable disease. The authors are all acknowledged experts in the emerging field of high-risk and advanced SCC.

Features
• Only text devoted to squamous cell carcinoma of the skin with a focus on high-risk tumors that may recur or metastasize
• Summaries of new prognostic information and staging systems allowing more precise definition of high-risk tumors
• Tips on practical management of challenging cases, including multiple tumors/field cancerization, high-risk tumors, nodal metastases, and unresectable disease

Author
Chrysalyne Schmults, MD, MSCE. Director, Mohs & Dermatologic Surgery Center. Brigham & Women’s Hospital. Department of Dermatology. 1153 Centre St., Suite 4349. Jamaica Plain, MA 02130, USA